PRESS RELEASE published on 11/03/2023 at 17:30, 10 months 17 days ago PDMR Notification & Director Shareholding
PRESS RELEASE published on 11/02/2023 at 19:20, 10 months 18 days ago PDMR Notification & Director Shareholding
PRESS RELEASE published on 11/01/2023 at 17:30, 10 months 19 days ago Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
PRESS RELEASE published on 10/24/2023 at 08:00, 10 months 27 days ago Portfolio company Harpoon Therapeutics announces up to $150 million private placement
PRESS RELEASE published on 10/06/2023 at 08:00, 11 months 14 days ago Unaudited NAV for September 2023
PRESS RELEASE published on 09/27/2023 at 08:01, 11 months 23 days ago Interim Results for the Six Months Ended 30 June 2023
PRESS RELEASE published on 09/14/2023 at 08:01, 1 year ago Notice of Results and Investor Presentation
Published on 09/20/2024 at 23:40, 2 hours 10 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 2 hours 20 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 2 hours 50 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 3 hours 20 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 3 hours 35 minutes ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 2 hours 51 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 4 hours 50 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 5 hours 35 minutes ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 5 hours 59 minutes ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 6 hours 3 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 8 hours 10 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 8 hours 10 minutes ago Mise à disposition du Rapport Financier Semestriel 2024